Misonix: The $518M deal for Bioventus to buy Misonix is now complete
Bioventus has completed its transaction to acquire Misonix in a $518 million cash-and-stock deal, and it could acquire another company soon.
Read full article »
President & CEO
Stavros G. Vizirgianakis
Misonix is a New York-based medical device company that designs, develops, manufactures, and markets invasive therapeutic ultrasonic equipment for tissue removal treatments.
Read more